The global preventive vaccines market accounted for a value of USD 27.

6 billion in 2015 and

is expected to reach USD 55 billion by 2021, growing at a CAGR of 12.4% during the forecast
period from 2016 to 2021.

The vaccines market is different from any other commodity market. Compared to the
pharmaceutical market, the vaccines market is relatively small, although growing fast. The
vaccines market is rather concentrated on both supply and demand sides. It is highly
regulated and largely dependent on public purchasers and donor policies. The vaccines
market has very distinct features that increase the complexity of assessing and understanding
pricing and procurement in their context. It is made up of individual markets for individual
vaccines or vaccine types, each with its own specificities, particularly on the supply side.

New candidates for vaccination against cancer and HIV, which are under development, are
also projected to hit the magical milestone. Multinational vaccine companies historically have
conducted much of the innovation, research, and development in the field of vaccine
production. The companies have used their significant revenues, global size, and deeper
expertise to fund these R&D efforts. New technologies are also being introduced to curb the
time and expense incurred on new vaccine discovery and production. However, despite the
success of vaccines, infectious diseases are still a major cause of illnesses worldwide. At
least 40 major infectious diseases are still uncontrolled by vaccination.

Global Preventive Vaccines Market- Market Dynamics

This study targets gaining a detailed overview of the dynamics of the preventive vaccines
market during the forecast period. It focuses on the need to develop strategic insights into the
global and country-level markets, taking into consideration the demand as a result of
awareness, government initiatives, birth rate etc. A holistic study of the market has been
carried out by incorporating various factors extending from country-specific demographic
conditions and market-specific microeconomic influences that were needed to analyze the
future trends of this market.

Drivers

The report details several factors driving the growth of the global preventive vaccines market.
Some of these are:

Increasing number of products

 Increasing awareness

Increasing investments in R&D

Technological advancements

Increasing government funded projects and associations promoting vaccination

Growing demand in the developing countries (China and India) of the Asia-Pacific
region

Restraints

High regulatory intervention and costs are turning out to be the major restraints for this
market.

The market has been segmented based on the type of vaccines and application. The segment
based on the type of vaccine includes live, attenuated vaccine, inactivated vaccines, subunit
vaccine, toxoid vaccines, conjugate vaccines, DNA vaccine, and recombinant vector vaccine.
The market segment based on applications has been further subdivided into pediatric vaccine
and adult vaccine. The pediatric vaccines include pneumococcal vaccine, varicella vaccine,
combination vaccines (Bivalent, trivalent, tetravalent, and pentavalent vaccines), MMR,
poliovirus, hepatitis, HIB, and other pediatric vaccines. The segment on adult vaccines
includes influenza, cervical cancer, hepatitis, zoster, and other adult vaccines.

There are currently close to 120 new vaccines in the pipeline of various companies across
the globe, set to hit the market in the next five years. In anticipation of this and with the
emergence of a new target market and smaller players in it, the global preventive vaccines
market is set to grow at a CAGR of close to 12.4 % by the year 2021.

Some of the key players in the market are:

Emergent BioSolutions

GlaxoSmithKline

Merck & Co.

Pfizer

Sanofi

What the Report Offers

 Market analysis for the global preventive vaccines market, with region-specific
assessments and competition analysis.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising

prospective opportunities, and identification of key companies that can influence this
market on a regional scale.

Extensively researched competitive landscape section with profiles of major

companies along with their market share.

Identification and analysis of the macro and micro factors that affect the global
preventive vaccines market.

A comprehensive list of key market players along with the analysis of their current
strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and
the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions in which this industry is blooming and to also
identify the regions that are still untapped.